CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 131 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $218,000 | -60.5% | 76,200 | -65.9% | 0.00% | -100.0% |
| Q2 2017 | $552,000 | -25.0% | 223,600 | +9.7% | 0.00% | -50.0% |
| Q1 2017 | $736,000 | +110.9% | 203,800 | +106.7% | 0.00% | +100.0% |
| Q4 2016 | $349,000 | -6.4% | 98,600 | +6.7% | 0.00% | 0.0% |
| Q3 2016 | $373,000 | +35.1% | 92,400 | +47.1% | 0.00% | 0.0% |
| Q2 2016 | $276,000 | +62.4% | 62,800 | +39.9% | 0.00% | 0.0% |
| Q1 2016 | $170,000 | -2.3% | 44,900 | +304.5% | 0.00% | 0.0% |
| Q4 2015 | $174,000 | -85.2% | 11,100 | -90.1% | 0.00% | -80.0% |
| Q3 2015 | $1,178,000 | +1410.3% | 111,784 | +3505.9% | 0.01% | – |
| Q2 2015 | $78,000 | -56.9% | 3,100 | -52.3% | 0.00% | -100.0% |
| Q1 2015 | $181,000 | – | 6,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,025,000 | $24,815,000 | 31.36% |
| TSP Capital Management Group, LLC | 836,342 | $20,248,000 | 8.80% |
| Iguana Healthcare Management, LLC | 200,000 | $4,842,000 | 2.76% |
| First Light Asset Management, LLC | 116,096 | $2,811,000 | 2.38% |
| SECTORAL ASSET MANAGEMENT INC | 2,227,688 | $53,932,000 | 2.33% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 550,735 | $13,334,000 | 2.05% |
| Eventide Asset Management | 257,000 | $6,222,000 | 1.92% |
| Redmile Group, LLC | 397,951 | $9,634,000 | 1.19% |
| ARDSLEY ADVISORY PARTNERS LP | 357,000 | $8,643,000 | 1.15% |
| Rhenman & Partners Asset Management AB | 90,000 | $2,179,000 | 0.85% |